Partial deletion of the long arm of chromosome 20 syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:262164
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Partial deletion of the long arm of chromosome 20 syndrome (also referred to as 20q deletion syndrome or monosomy 20q) is a rare chromosomal disorder caused by the loss of a segment of genetic material from the long arm (q arm) of chromosome 20. The clinical presentation varies considerably depending on the size and precise location of the deleted segment. Because chromosome 20 contains numerous genes involved in development and cellular function, deletions in this region can affect multiple body systems. Commonly reported features include intellectual disability of variable severity, developmental delay (particularly speech and motor milestones), growth retardation, and distinctive craniofacial features such as a broad or prominent forehead, short nose, low-set ears, and micrognathia. Some individuals may also present with skeletal anomalies, cardiac malformations, feeding difficulties in infancy, and behavioral abnormalities. The phenotype is highly variable and correlates with the specific breakpoints and extent of the deletion. There is no specific curative treatment for this chromosomal condition. Management is supportive and symptom-based, typically involving a multidisciplinary team including developmental pediatricians, speech and occupational therapists, cardiologists if heart defects are present, and genetic counselors. Early intervention programs for developmental delays are recommended. Diagnosis is confirmed through chromosomal microarray analysis or karyotyping, which can precisely define the deleted region and help guide prognosis and management.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Partial deletion of the long arm of chromosome 20 syndrome.

View clinical trials →

No actively recruiting trials found for Partial deletion of the long arm of chromosome 20 syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Partial deletion of the long arm of chromosome 20 syndrome community →

No specialists are currently listed for Partial deletion of the long arm of chromosome 20 syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Partial deletion of the long arm of chromosome 20 syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Partial deletion of the long arm of chromosome 20 syndromeForum →

No community posts yet. Be the first to share your experience with Partial deletion of the long arm of chromosome 20 syndrome.

Start the conversation →

Latest news about Partial deletion of the long arm of chromosome 20 syndrome

No recent news articles for Partial deletion of the long arm of chromosome 20 syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Partial deletion of the long arm of chromosome 20 syndrome

What is Partial deletion of the long arm of chromosome 20 syndrome?

Partial deletion of the long arm of chromosome 20 syndrome (also referred to as 20q deletion syndrome or monosomy 20q) is a rare chromosomal disorder caused by the loss of a segment of genetic material from the long arm (q arm) of chromosome 20. The clinical presentation varies considerably depending on the size and precise location of the deleted segment. Because chromosome 20 contains numerous genes involved in development and cellular function, deletions in this region can affect multiple body systems. Commonly reported features include intellectual disability of variable severity, develop

At what age does Partial deletion of the long arm of chromosome 20 syndrome typically begin?

Typical onset of Partial deletion of the long arm of chromosome 20 syndrome is neonatal. Age of onset can vary across affected individuals.